KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses ...Middle East

PITTSBURGH, May 23, 2022 /PRNewswire/ -- KaliVir Immunotherapeutics, Inc. today announced a collaboration and global exclusive licensing agreement with Roche for the discovery, development and commercialization of novel oncolytic vaccinia viruses derived from KaliVir's oncolytic...

Hence then, the article about kalivir immunotherapeutics enters into global exclusive licensing agreement with roche for novel oncolytic viruses was published today ( Monday 23/05/2022 - 09:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses )

Also on site :

• Merz rejects Zelensky’s ‘concrete date’ for EU membership
• Driver ‘intentionally’ rams car into synagogue in New York (VIDEO)
• Costco Is Selling a Stunningly Soft 3-Piece Quilt Set With a 'Neutral but Unique Print'